Protein glycosylation is fundamentally important to most biological processes and it is often important to regulate it in biopharmaceutical development. Thus, substantial efforts have been taken to engineer glycosylation of a variety of biologics. However, the diversity and complexity of glycosylation have made it difﬁcult to control glycosylation and unravel how engineering efforts impact the host cells.
|Conference||2018 Annual Meeting of the Society for Glycobiology |
|Location||Hilton New Orleans Riverside|
|Period||05/11/2018 → 08/11/2018|
Lewis, N. E., Chiang, A. W. T., Bao, B., Kuo, C., Kellman, B., Richelle, A., Liang, A., Arnsdorf, J., Sukhova, Z.
, Ménard, P., Hansen, A. H.
, Yang, Z., Joshi, H., Clausen, H., & Voldborg, B. G.
(2018). The cellular impact of glycoengineering
(12), 1074-1074. https://doi.org/10.1093/glycob/cwy088